Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report

Código QR

Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report

There are no effective therapeutic options for locally advanced head and neck squamous cell carcinoma (HNSCC). Additionally, there is no standard therapy for patients subjected to multiple lines of treatment. Angiogenesis plays a key role in tumor growth and metastasis. Therefore, inhibition of tumo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	He Jian, Zhang Yangyang, Gao Jin, Qian Liting
Formato:	article
Lenguaje:	EN
Publicado:	De Gruyter 2021
Materias:	apatinib oral cancer head and neck squamous cell carcinoma vegfr-2 Medicine R
Acceso en línea:	https://doaj.org/article/a2e96ccf0924411f9ffcf5462331a89e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Oral and Oropharyngeal Squamous Cell Carcinoma in Our Population: The Clinic-Pathological and Morphological Description of 153 Cases
por: Agarwal,A. K, et al.
Publicado: (2011)

Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?
por: Iago Ferreira, et al.
Publicado: (2021)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xuanli Xu, et al.
Publicado: (2021)

Rare Metastasis to the Submandibular Gland in Oral Squamous Cell Carcinoma
por: Ping Zhou, et al.
Publicado: (2021)

Clinicopathological Profile of Oral Squamous Cell Carcinoma in Eastern India
por: Surendra Nath Senapati, et al.
Publicado: (2021)

Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma
por: Will OM, et al.
Publicado: (2016)

Acantholytic Squamous Cell Carcinoma
por: Sandy Maganito, et al.
Publicado: (2021)

Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma
por: Gunnar Wichmann, et al.
Publicado: (2021)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
por: Farzaneh Kordbacheh, et al.
Publicado: (2021)

New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas
por: Cristina Porcheri, et al.
Publicado: (2021)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
por: Qian X, et al.
Publicado: (2021)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Shun Liu, et al.
Publicado: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
por: Jerry Polesel, et al.
Publicado: (2021)

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
por: Song C, et al.
Publicado: (2020)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
por: Lucrezia Togni, et al.
Publicado: (2021)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Shinsuke Suzuki, et al.
Publicado: (2021)

4NQO Carcinogenesis: A Model of Oral Squamous Cell Carcinoma
por: Rivera Martínez,César Andrés
Publicado: (2012)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Karl Payne, et al.
Publicado: (2021)

Immunoexpression of p53 in Oral Squamous Cell Carcinoma and Oral Dysplastic Lesions in Patients with the Habit of Reverse Smoke
por: Álvarez Martínez,Efraín, et al.
Publicado: (2013)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
por: Fu L, et al.
Publicado: (2021)

Assessment of Tumor Associated Tissue Eosinophilia (TATE) in Oral Squamous Cell Carcinoma Using Carbol Chromotrope Stain
por: Peter,Celestina Dawn, et al.
Publicado: (2015)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Xinwen Wang, et al.
Publicado: (2021)

Oral Squamous Cell Carcinoma Associated with Arsenic Exposure: A Case Series from Argentina
por: Leonardi,Nicolás, et al.
Publicado: (2020)

Late Diagnosis of Oral Melanoma
por: Santana,Lucas Alves da Mota, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
por: Philipp Baumeister, et al.
Publicado: (2021)

Immunohistochemical Analysis of the Beclin-1 Expression Predicts the Progression of Oral Squamous Cell Carcinoma
por: Ida Barca, et al.
Publicado: (2021)

The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth
por: Hassan CE, et al.
Publicado: (2016)

p53 Immunoexpression in Oral Squamous Cell Carcinomas from Different Anatomical Sites: A Comparative Study
por: Sá,Cláudia T., et al.
Publicado: (2006)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
por: Pei-Hung Chang, et al.
Publicado: (2021)

Immunoexpression of Cell Proliferation Markers in Oral Squamous Cell Carcinoma
por: Pereira,Joabe dos Santos, et al.
Publicado: (2016)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ying-Peng Peng, et al.
Publicado: (2021)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Xing-xing Huo, et al.
Publicado: (2021)

IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
por: Alena Gribko, et al.
Publicado: (2021)

Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
por: Jo Omata, et al.
Publicado: (2021)

Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
por: Anisha Gehani, et al.
Publicado: (2021)

Locally advanced basal cell carcinoma of the auricle and parotid region: A case report
por: Milanović Srđan, et al.
Publicado: (2021)

The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
por: Enhao Wang, et al.
Publicado: (2021)

Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
por: Mengxue Zhang, et al.
Publicado: (2021)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi N, et al.
Publicado: (2021)

Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
por: Song Z, et al.
Publicado: (2017)